Entries by

New research award to our partners at Radboudumc

Our partners at Radboud University Medical Centre Nijmegen (Radboudumc) wrote a two-year project proposal called “Breaking the circle: Interleukin-1β stimulation of adipose stem cells increases their therapeutic efficacy in posttraumatic osteoarthritis via potentiation of anti-inflammatory actions in neutrophils”. This study is now funded by the Dutch Arthritis Association. Congratulations to the whole team! The research team at […]

ADIPOA-2 publication in Biomaterials journal

Congratulations to the team of  Maxime Ruiz, Karine Toupet, Marie Maumus, Pauline Rozier, Christian Jorgensen and Daniéle Noel for the publication of the paper “TGFBI secreted by mesenchymal stromal cells ameliorates osteoarthritis and is detected by extracellular vesicles.” The open access paper published in Biomaterials 226 (2020) 119544 was made available online on 11 October […]

ADIPOA-2 presented by PI Yves-Marie Pers at ISCT 2019 in Mexico

ADIPOA-2 PI Yves-Marie Pers, M.D., PhD. of INSERM Montpellier gave an oral presentation at the International Society for Cell and Gene Therapy (ISCT) meeting in Mexico City on 23 October 2019. The title of his talk was “Mesenchymal stem cells: from bench to bedside” where ADIPOA-2 was presented and acknowledged. Approximately 200 people attended Yves’ talk. […]

Pintail hosts ADIPOA-2 plenary meeting, 3 September 2019 in Dublin

The ADIPOA-2 consortium met for a plenary meeting on September 3, 2019, in Dublin. This was a critical meeting to assess progress, obstacles and achievements in the ADIPOA2 clinical trial.  Every partner in the clinical, manufacturing and scientific arenas was represented.  Some key points have emerged during this project summit meeting on which all the […]

New ADIPOA-2 publication from Istituto Ortopedico Rizzoli di Bologna

Congratulations to the ADIPOA-2 team at the Istituto Ortopedico Rizzoli di Bologna for their latest publication in the Journal of Orthopaedic Research: “Osteoarthritic milieu affects adipose-derived mesenchymal stromal cells”. The research was conducted by the team of C Manferdini, F Paolella, E Gabusi, L Cattini, M Rojewski, H Schrezenmeier, O Addimanda, R Meliconi, G Lisignoli. […]

IOR researchers present ADIPOA-2 at Stem Cell Research Italy meeting; Dr Manferdini takes first prize

ADIPOA-2 researchers at the Rizzoli Orthopaedic Institute in Bologna, Dr Gina Lisignoli and Dr Cristina Manferdini of the Laboratory di Immuno-rheumatology and Tissue Regeneration have presented two ADIPOA-2 studies at the 10th Stem Cell Research Italy meeting. Hosted in Napoli, the meeting took place on June 5-7, 2019. Dr Manfredini was awarded the first prize for the […]

International Clinical Trials Day 2019, Galway

The HRB Clinical Research Facility Galway in Ireland hosted a public event to celebrate International Clinical Trials Day on May 20th 2019. Exhibition stands were on display and informational meetings were held throughout the day to inform the public of all areas of clinical research being undertaken at the facility. A particular stand was dedicated to […]

Radboud University Medical Centre publish ADIPOA-2 study

The study “IL-1β-mediated activation of adipose-derived mesenchymal stromal cells results in PMN reallocation and enhanced phagocytosis. A possible mechanism for the reduction of osteoarthritis pathology” by the team of Stephanie C.M. van Dalen, Arjen B. Blom, Birgitte Walgreen, Annet W. Slöetjes, Monique M.A. Helsen, Edwin J.W. Geven, Thomas Vogl, Johannes Roth, Fons A.J. van de […]